According to a new market research report published by Global Market
Estimates, the Global Companion Animal Pharmaceuticals Market is projected to
grow from USD 13.2 billion in 2022 to USD 19.5 billion by 2027 at a CAGR value
of 7.8% from 2022 to 2027.
Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, Ceva Santé Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals plc, Chanelle Pharma, Kyoritsu Seiyaku, among others are the key players in the companion animal pharmaceuticals market.
The rapidly increasing number of pet ownership, accelerated commitment of owners to pay for optimal healthcare, expanded pet life expectancies, and the introduction of age-related illness targets such as rheumatoid arthritis, cancers, and obesity are all contributing to an explosive growth trend in the companion animal health sector during the forecast period.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Visually Impaired Assistive Apps Market - Forecast to 2027” https://www.globalmarketestimates.com/market-report/companion-animal-pharmaceuticals-market-3773
Indication Outlook (Revenue, USD Billion, 2022 - 2027)
· Infectious Diseases
· Dermatologic Diseases
· Orthopedic Diseases
· Behavioral Diseases
· Other Indications
Animal Type Outlook (Revenue, USD Billion, 2022 - 2027)
· Other Companion Animals
Distribution Channel Outlook (Revenue, USD Billion, 2022 - 2027)
· Veterinary Hospitals
· Veterinary Clinics
· Retail Pharmacies
Regional Outlook (Revenue, USD Billion, 2022-2027)
- The U.S.
- Rest of Europe
- South Korea
- Rest of APAC
Central & South America
- Rest of CSA
Middle East & Africa
- Saudi Arabia
- Rest of MEA
Contact: Yash Jain
Email address: firstname.lastname@example.org
Phone Number: +16026667238